| Literature DB >> 24093889 |
Abstract
BACKGROUND: The aim of this study was to identify key genes and novel potential therapeutic targets related to gastric cancer (GC) by comparing cancer tissue samples and healthy control samples using DNA microarray analysis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24093889 PMCID: PMC3852022 DOI: 10.1186/2047-783X-18-37
Source DB: PubMed Journal: Eur J Med Res ISSN: 0949-2321 Impact factor: 2.175
Figure 1Boxplot for normalized gene expression data and cluster analysis results. (a) Boxplot of gene expression data. The medians are almost at the same level, indicating high normalization performance. (b) Cluster analysis results for gene expression data. The expression values clustered in the purple/magenta-shaded areas indicate overexpression, and the green-shaded areas indicate underexpression.
Functional enrichment analysis of the upregulated and downregulated differentially expressed genes
| Upregulated DEGs | ||
| [GO:0022402] Cell-cycle process | 30 | 1.50E-05 |
| [GO:0007049] Cell cycle | 35 | 3.70E-05 |
| [GO:0022403] Cell-cycle phase | 24 | 1.43E-04 |
| [GO:0000278] Mitotic cell cycle | 22 | 3.82E-04 |
| [GO:0007155] Cell adhesion | 30 | 0.00146 |
| [GO:0022610] Biological adhesion | 30 | 0.001503 |
| [GO:0006928] Cell motion | 24 | 0.001626 |
| [GO:0042981] Regulation of apoptosis | 32 | 0.00271 |
| [GO:0043067] Regulation of programmed cell death | 32 | 0.003334 |
| [GO:0010941] Regulation of cell death | 32 | 0.0036 |
| [GO:0006259] DNA metabolic process | 24 | 0.004784 |
| [GO:0009611] Response to wounding | 24 | 0.010324 |
| [GO:0001501] Skeletal system development | 18 | 0.013141 |
| [GO:0051301] Cell division | 17 | 0.0199 |
| [GO:0051726] Regulation of cell cycle | 18 | 0.021567 |
| Downregulated DEGs | ||
| [GO:0042127] Regulation of cell proliferation | 48 | 3.72E-04 |
| [GO:0008284] Positive regulation of cell proliferation | 32 | 4.67E-04 |
| [GO:0006873] Cellular ion homeostasis | 30 | 5.59E-04 |
| [GO:0006955] Immune response | 43 | 0.001061657 |
| [GO:0055080] Cation homeostasis | 25 | 0.001479293 |
| [GO:0019226] Transmission of nerve impulse | 27 | 0.005126019 |
| [GO:0019725] Cellular homeostasis | 32 | 0.005850539 |
| [GO:0007610] Behavior | 32 | 0.006669845 |
| [GO:0007586] Digestion | 13 | 0.009844162 |
| [GO:0006875] Cellular metal ion homeostasis | 19 | 0.010226535 |
| [GO:0055065] Metal ion homeostasis | 19 | 0.019086885 |
| [GO:0030003] Cellular cation homeostasis | 21 | 0.031550799 |
| [GO:0007268] Synaptic transmission | 23 | 0.033256699 |
aDEG, differentially expressed gene; FDR, false discovery rate.
Figure 2Gene expression levels of (a) and (b) in each sample. (a)FABP4 is downregulated in gastric cancer (GC) tissue. (b)SPP1 is upregulated in GC tissue.
Figure 3Interaction networks including or . (a) The network that involved FABP4 based on HitPredict database, with the green lines indicating high-confidence, small-scale binary; the blue lines indicating high-confidence, small-scale–derived; the black lines indicating high-confidence, high-throughput; and the dashed black lines indicating spurious small-scale or high-throughput. (b) The network that involved SPP1 based on the STRING database.
Overrepresented functional annotation terms in the network including
| [KEGG:hsa04512]: ECM-receptor interaction | 25 | 1.01E-31 |
| [KEGG:hsa04510]: Focal adhesion | 26 | 1.76E-23 |
| [KEGG:hsa05410]: Hypertrophic cardiomyopathy (HCM) | 20 | 1.11E-21 |
| [KEGG:hsa05414]: Dilated cardiomyopathy | 20 | 5.79E-21 |
| [KEGG:hsa05412]: Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 19 | 8.03E-21 |
| [KEGG:hsa04810]: Regulation of actin cytoskeleton | 20 | 1.11E-13 |
| [KEGG:hsa04640]: Hematopoietic cell lineage | 8 | 0.003148 |
| [KEGG:hsa05200]: Pathways in cancer | 13 | 0.003491 |
ECM, extracellular matrix; FDR, false discovery rate.